This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 Oct 2021

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

Michael Collins, Founder and CEO of CEM Corporation and Chris Bai, Co-Founder and CEO of AmbioPharm, Inc.

CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market.

Mentioned Companies
AmbioPharm, Inc.
View company profile